(NASDAQ:MDGL), Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced fibrosis, resolved MASH and improved key noninvasive tests Rezdiffra is already included in European MASH treatment guidelines as a […]

(Other OTC:ETST),(OTC US:ETST), Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of Directors has approved a reduction of the Company's authorized shares of common stock from 350 million to

(NASDAQ:SRPT), NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22,

Fluent Announces Second Quarter 2025 Financial Results; Commerce Media Solutions Annual Revenue Run Rate Exceeds $80 Million GlobeNewswire August 19, 2025 • Q2 2025 revenue of $44.7 million; H1 2025 revenue of $99.9 million • Q2 2025 Commerce Media Solutions revenue grew 121% to $16.1 million, representing 36% of consolidated revenue from $7.3 million or

CTO Realty Growth Declares Dividends for the Third Quarter 2025 GlobeNewswire August 19, 2025 WINTER PARK, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared, a quarterly cash dividend of $0.38 per share

Alpine Income Property Trust Declares Dividend for the Third Quarter 2025 GlobeNewswire August 19, 2025 WINTER PARK, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared, a quarterly cash dividend of $0.285 per share

Madrigal Receives European Commission Approval for Rezdiffra(TM) (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis GlobeNewswire August 19, 2025 Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial

Carlyle Credit Income Fund Announces Third Quarter Financial Results and Declares Monthly Common and Preferred Dividends GlobeNewswire August 19, 2025 NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) today announced its financial results for its third quarter ending June 30, 2025. The

Sarepta Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Sarepta Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – SRPT GlobeNewswire August 19, 2025 NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ:

Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock GlobeNewswire August 19, 2025 Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of Directors has approved